RNA
Research Areas
Products Related to RNA(29)
- GM10022Cy5 mCherry mRNA with N1-Me-pUTP (5'CAP)
Cy5 mCherry mRNA with N1-Me-pUTP (5'CAP) is a fluorescent reporter gene commonly used in molecular biology research. Cy5 mCherry mRNA with N1-Me-pUTP (5'CAP) is produced through in vitro transcription. By simulating the mRNA processing process in eukaryotes, it has a 5 'end Cap 1 cap structure, a 3' end poly (A) tail, Cy5-UTP modification, and N1-Me-pUTP modification (Cy5-UTP: N1-Me-pUTP=3:1 (molar ratio)), which increases the stability and translation efficiency of mRNA.
- GM10023Cy5 OVA mRNA (5'CAP)Purity: >98%
Cy5 OVA mRNA (5'CAP) is produced through in vitro transcription, which simulates the mRNA processing process in eukaryotes. It has a 5 'end Cap 1 cap structure, a 3' end poly (A) tail, and Cy5-UTP modification (Cy5-UTP: UTP=3:1 (molar ratio)), increasing the stability and translation efficiency of mRNA [1] .
- GM10024Cy5 OVA mRNA with N1-Me-pUTP (5'CAP)Purity: >98%
Cy5 OVA mRNA with N1-Me-pUTP (5'CAP) is produced through in vitro transcription. By simulating the mRNA processing in eukaryotes, it has a 5 'end Cap 1 cap structure, a 3' end poly (A) tail, Cy5-UTP modification, and N1-Me-pUTP modification (Cy5-UTP: N1-Me-pUTP=3:1 (molar ratio)), which increases the stability and translation efficiency of mRNA.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GM10022 | Cy5 mCherry mRNA with N1-Me-pUTP (5'CAP) | - | - | |
Cy5 mCherry mRNA with N1-Me-pUTP (5'CAP) is a fluorescent reporter gene commonly used in molecular biology research. Cy5 mCherry mRNA with N1-Me-pUTP (5'CAP) is produced through in vitro transcription. By simulating the mRNA processing process in eukaryotes, it has a 5 'end Cap 1 cap structure, a 3' end poly (A) tail, Cy5-UTP modification, and N1-Me-pUTP modification (Cy5-UTP: N1-Me-pUTP=3:1 (molar ratio)), which increases the stability and translation efficiency of mRNA. | ||||
| GM10023 | Cy5 OVA mRNA (5'CAP) | - | >98% | |
Cy5 OVA mRNA (5'CAP) is produced through in vitro transcription, which simulates the mRNA processing process in eukaryotes. It has a 5 'end Cap 1 cap structure, a 3' end poly (A) tail, and Cy5-UTP modification (Cy5-UTP: UTP=3:1 (molar ratio)), increasing the stability and translation efficiency of mRNA [1] . | ||||
| GM10024 | Cy5 OVA mRNA with N1-Me-pUTP (5'CAP) | - | >98% | |
Cy5 OVA mRNA with N1-Me-pUTP (5'CAP) is produced through in vitro transcription. By simulating the mRNA processing in eukaryotes, it has a 5 'end Cap 1 cap structure, a 3' end poly (A) tail, Cy5-UTP modification, and N1-Me-pUTP modification (Cy5-UTP: N1-Me-pUTP=3:1 (molar ratio)), which increases the stability and translation efficiency of mRNA. | ||||
| GC79710 | ATX-012 | 1777792-44-5 | >98% | |
ATX-012 is an ionizable cationic lipid for the assembly of mRNA -delivering lipid nanoparticles (LNPs). | ||||
| GC81662 | nor-MC3 | 2870681-06-2 | >98.00% | |
nor-MC3 is an MC3 -type ionizable lipid with C 17 unsaturated chains, formulated in lipid nanoparticles for nucleic acid ( mRNA and siRNA) delivery and supports in vitro and in vivo transfection [1] . | ||||
